Valuation: Provexis plc

Market Cap 25.22M 33.66M 29.57M 27.41M 47.63M 3.22B 48.62M 327M 128M 1.58B 126M 124M 5.47B P/E 2024
-20.9x
P/E 2025 -22.6x
Enterprise Value 24.51M 32.71M 28.74M 26.64M 46.29M 3.13B 47.26M 318M 124M 1.54B 123M 120M 5.32B EV / Sales 2024
17x
EV / Sales 2025 7.62x
Free-Float
79.16%
Yield 2024 *
-
Yield 2025 -
1 day+8.43%
1 week+7.14%
Current month+5.88%
1 month+43.62%
3 months+42.11%
6 months+35.00%
Current year+50.00%
1 week 1.14
Extreme 1.14
1.35
1 month 0.8
Extreme 0.803
1.35
Current year 0.77
Extreme 0.77
1.55
1 year 0.55
Extreme 0.55
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer 52 01/01/2000
Director TitleAgeSince
Director/Board Member - 11/11/2010
Chairman 79 01/06/2005
Director/Board Member 52 12/04/2019
Date Insider Type Main position Quantity % Market Cap.
07/01/25Free

Chief Executive Officer

30,000,000 1.2788%
24/01/23Free

Chief Executive Officer

17,000,000 0.7665%
24/01/23Free

Chief Technology Officer

17,000,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
+8.43%+7.14%+68.75%+125.00% 39.19M
-1.99%-6.23%+28.92%+77.59% 13B
-2.97%+2.29%-26.11%+245.29% 7.95B
-0.75%-1.18%-20.28%-55.53% 2.3B
+2.15%-2.40% - - 1.46B
+2.16%-8.01%-77.99%-64.06% 1.45B
-0.38%-0.08%+28.68%-0.30% 1.36B
+1.83%-1.48%-29.63%-25.77% 1.23B
+0.19%-0.31%+20.51%+50.58% 1.23B
+4.23%-3.06%-59.53%-63.43% 1.13B
Average +1.29%-0.82%-7.41%+32.15% 3.11B
Weighted average by Cap. -1.22%+0.06%-0.96%+90.97%

Financials

2024 2025
Net sales 802K 1.07M 940K 872K 1.51M 102M 1.55M 10.4M 4.07M 50.31M 4.01M 3.93M 174M 1.29M 1.72M 1.52M 1.4M 2.44M 165M 2.49M 16.76M 6.56M 81.07M 6.47M 6.34M 280M
Net income -586K -782K -687K -637K -1.11M -74.85M -1.13M -7.6M -2.97M -36.78M -2.93M -2.87M -127M -453K -604K -531K -492K -855K -57.8M -873K -5.87M -2.3M -28.4M -2.27M -2.22M -98.17M
Net Debt -189K -253K -222K -206K -358K -24.18M -365K -2.46M -961K -11.88M -948K -928K -41.06M -708K -945K -830K -770K -1.34M -90.41M -1.37M -9.18M -3.59M -44.42M -3.54M -3.47M -154M
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
13/07/26 GBX 1.350 +8.43% 1,303,087
10/07/26 GBX 1.245 +2.05% 2,043,759
09/07/26 GBX 1.220 -2.01% 127,280
08/07/26 GBX 1.245 +3.32% 212,568
07/07/26 GBX 1.205 -3.98% 3,856,734